凯尼克萨制药 KNSA
$93.86 +$5.52 (+6.25%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $95.00 +1.21%
开盘$88.92
昨收$88.34
当日区间$88.41 – $94.48
成交量636.3K
市值$7.37B
市盈率（TTM）71.1
股息率–
财报
财报日平均波动±13.2%近16次财报
收涨次数10 / 1663% 的概率
最佳反应+30.4%
最差反应-15.7%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q3 | 27 Oct 2026 | Pre Market | ±13.4% | +22.23% | 超出定价预期 |
| 2026/Q2 | 28 Jul 2026 | None | ±10.4% | +25.03% | 超出定价预期 |
| 2026/Q1 | 28 Apr 2026 | Pre Market | ±14.5% | +23.48% | 超出定价预期 |
| 2025/Q4 | 24 Feb 2026 | Pre Market | ±16.1% | -8.21% | 符合区间 |
| 2025/Q3 | 28 Oct 2025 | None | ±13.4% | -2.88% | 符合区间 |
| 2025/Q2 | 29 Jul 2025 | Pre Market | ±13.5% | +12.32% | 符合区间 |
| 2025/Q1 | 29 Apr 2025 | Pre Market | ±14.1% | +20.54% | 超出定价预期 |
| 2024/Q4 | 25 Feb 2025 | Pre Market | ±15.2% | +0.46% | 符合区间 |
| 2024/Q3 | 29 Oct 2024 | Pre Market | ±15.2% | -15.68% | 超出定价预期 |
| 2024/Q2 | 23 Jul 2024 | None | ±10.0% | +22.91% | 超出定价预期 |
| 2024/Q1 | 23 Apr 2024 | Pre Market | ±15.5% | +3.42% | 符合区间 |
| 2023/Q4 | 28 Feb 2024 | Pre Market | ±16.7% | -2.54% | 符合区间 |
| 2023/Q3 | 31 Oct 2023 | Pre Market | ±15.2% | -2.74% | 符合区间 |
| 2023/Q2 | 25 Jul 2023 | Pre Market | ±19.2% | +30.39% | 超出定价预期 |
| 2023/Q1 | 2 May 2023 | Pre Market | ±13.2% | +14.66% | 超出定价预期 |
| 2022/Q4 | 28 Feb 2023 | Pre Market | ±16.5% | -3.45% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q3, ended Sep 2026
营收$285.97M+58.1% YoY
营业利润$54.24M+125.8% YoY
净利润$47.35M+156.8% YoY
摊薄每股收益$0.56+143.5% YoY
自由现金流$47.37M+43.5% YoY
经营现金流$47.55M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率54.3%
营业利润率13.8%
净利率11.6%
净资产收益率17.6%
资产收益率12.9%
投入资本回报率17.3%
流动比率3.91
负债/资产比率27.8%
现金及投资$568.76M
总负债$3.92M
净现金（净负债）$564.84M
自由现金流/营收20.8%
暂无评论——快来第一个聊聊 KNSA。
登录后参与讨论。